Global Biotechnology Reagents Industry

  • April 2012
  • -
  • Global Industry Analysts
  • -
  • 925 pages

This report analyzes the worldwide markets for Biotechnology Reagents in US$ Million by the following Product Segments: Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 267 companies including many key and niche players such as Abbott Diagnostics, Beckman Coulter, Inc., Becton Dickinson and Company, BioMérieux SA, EMD Biosciences, Inc., EMD Millipore Corporation, Fitzgerald Industries International, GE Healthcare, Life Technologies Corporation, Ortho-Clinical Diagnostics, PerkinElmer, Inc., Promega Corporation, Roche Diagnostics Ltd., Siemens Healthcare Diagnostics, Inc., and Sigma - Aldrich. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-3
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Cell and Tissue Culture Reagents I-4
DNA Synthesis and Sequencing Reagents I-4
Electrophoresis Reagents I-4
Flow Cytometry Reagents I-4
Immunoassay Reagents I-5
Liquid Chromatography Reagents I-5
PCR Reagents I-5
Protein Synthesis and Sequencing Reagents I-5


II. EXECUTIVE SUMMARY

1. OUTLOOK II-1
Reagents Market Players Witness Paradigm Shift II-1

2. MARKET DYNAMICS II-2
Highly Automated Instrumentation Restricts Use of Reagents II-2
Software-Intensive Nature and High System Complexity Impedes
Use of Automated Instruments II-2
Demand for Diverse Products Spurs Growth II-2
Increasing Use in Industrial Sector II-2
Molecular Biology and Protein Synthesis Reagents - the Fastest
Growing Segments II-3
Obtaining Data from Enzyme Functions II-3
New Economy Sees the Entry of Directed Evolution Enzymes II-3

3. BIOTECHNOLOGY - INDUSTRY OVERVIEW II-4
Growing by Leaps and Bounds II-4
Human Genome Mapping - A Colossal Milestone II-4
High Growth Applications Spur Industry Growth II-5
Biochips- Promising Future II-5
Convergence of Distinct Technologies II-6
Growing Collaboration between Biotech and Pharma Companies II-6

4. PRODUCT OVERVIEW II-7
A. Classification II-7
i. DNA Synthesis and Sequencing Reagents II-7
DNA: The Basis for Modern Biotechnology II-7
ii. PCR Reagents II-7
iii. Protein Synthesis and Sequencing Reagents II-7
iv. Electrophoresis Reagents II-8
v. Bio/Chemiluminescence Reagents II-8
vi. Immunoassay Reagents II-8
Antibodies II-8
Monoclonal and Polyclonal Antibodies II-8
Types of Monoclonal Antibodies II-8
a. Murine Monoclonal Antibodies II-8
b. Human Antibodies II-8
c. Chimeric Antibodies II-9
d. Bispecific Antibodies II-9
Hematology/Coagulation Reagents II-9
vii. Chromatography Reagents II-9
viii. Flow Cytometry Reagents II-9
ix. Cell and Tissue Culture Reagents II-9

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-11
iCyt Introduces Synergy and Eclipse Flow Cytometry Products II-11
Millipore Unveils Luminataâ„¢ HRP Detection Reagents II-11
Agilent Technologies Introduces Advanced PCR Reagents II-12
InVitria Unveils Zap-Hybridoma II-12
Dionex Releases Reagent-Free Ion Chromatography system II-12
Aurora Releases PCR Fluorescent Probing Diagnostic Reagent Kits II-13
Applied Biosystems Launches Acoustic Focusing Cytometer II-13
BD Biosciences Unveils BD Kaleidoscope Reagent II-14
Advancell Launches Isocyp-Toxâ„¢ Cellular Reagent II-14
Applied Biosystems Introduces Latest Genetic Analyzers Lines II-14
Kollodis BioSciences Launches MAPTrix® ECM Range of Reagents II-15
Thermo Fisher Scientific Unveils FILLitâ„¢ Software II-15
Kapa Biosystems Rolls Out KAPA2Gâ„¢ Fast HotStart DNA Polymerase II-15
DuPont Releases DuPontâ„¢ PCR Reagent Kits II-16
Applied Biosystems Unveils Sequencing-Based Tools for Whole
Transcriptomes II-16

6. PRODUCT INNOVATIONS/LAUNCHES - A HISTORIC PERSPECTIVE BUILDER II-18
454 Life Sciences Rolls Out GS FLX Titanium Range of Software
and Agents II-18
Trinity Biotech Introduces New Lyme Products in Europe II-18
Stratagene Launches Quantitative PCR Reagents II-18
Thermo Fisher Introduces Non-Serum Medium for Adherent CHO Cells II-19
Accuri Introduces Advanced Accuri C6 Flow Cytometerâ„¢ System II-19
Invitrogen Introduces In-Vivo RNAi Delivery Reagent II-20
Invitrogen Introduces Stem Cell Culture Services II-20
Beckman Coulter Introduces Two IOTest® Reagents II-20
Applied Biosystems Announces New Reagents II-21
Calypte Biomedical Introduces New Calypte Life Sciences Family
of Products II-22
Applied Biosystems Launches TaqMan® Cells-to-CT™ Kit Solutions II-22
Applied Biosystems Launches iTRAQ® Reagents II-22
PerkinElmer Launches Series 275 HResâ„¢ LC System II-23
Sigma-Aldrich Introduces Imprintâ„¢ ChIP Kit II-23
Stratagene Introduces Expanded QPCR, QRT-PCR Reagents Line II-23
Asuragen Introduces Signature® LTx in Markets Worldwide II-23
Biomatrica Launches PCRboostâ„¢ - A New Reagent II-24
Genetix Group Launches New CytoGenetix FISH Kits and Reagents II-24
Strategic Diagnostics Introduces New Online Catalog of
Antibody Reagents II-25
Bioatlas Expands Bioatlas Product Lineup with Atlas Antifade II-25
ScienceXperts and Invitrogen Develop Flow Cytometry Software II-25
Beckman Coulter Launches Cell Signal Transduction Reagents II-25
Sigma-Aldrich Launches LentiExpressâ„¢ Technology II-26
Abbott Unveils New Assays and Reagents II-26
Applied Biosystems Introduces New Master Mix Reagent II-26
Promega Designs Advanced Luciferase Assay II-26
Ortho-Clinical Diagnostics Expands Test-Base for Infectious
Diseases II-27
Genetix Launches Two Novel ''CloneMedia'' Semi-Solid Media
Products II-27
Invitrogen Launches Lipofectamine LTX II-27
Beckman Coulter Launches IOTest® Anti-Rat Flow Cytometry Reagents II-28
EMD Biosciences Introduces ProteoPlex® Human Angiogenesis Array II-28
AspenBio Pharma Launches New Single-Chain Gonadotropin II-28
Ortho-Clinical Diagnostics Launches VITROS® Chemistry Products
d%A1c Reagent II-28
Beckman Coulter to Launch Access DHEA-S II-29
Solulink Introduces ChromaLink II-29
Cambrex Launches Versalinx Reagents II-29
Kreatech Unveils a New Range of Isolation and Labeling Kits II-29
Nanogen Launches Enterovirus Analyte Specific Reagent - MGB
Alertâ„¢ II-29
Olympus Unveils New Reagent Kit with Single Molecular
Fluorescence Spectroscopy II-29
SAFC Releases Proligo Reagents II-30
LI-COR Biosciences Releases New IRDye® Western Kits for
Odyssey® System II-30
Altor Launches STARâ„¢ Multimer Reagents II-30
Guava Technologies Launches a New Range of Antibody Reagents II-30
Solexa Launches Genome Analysis System II-30
Daiichi Unveils New Reagent Kit II-30
Beckman Coulter Introduces Cellular Research Reagents II-31
ReaMetrix Introduces Accuford II-31
TriPath Imaging Unveils ProEx C II-31
Roche and 454 Life Sciences Launches Genome Sequencer 20
System and Reagents II-31
Chinese Academy of Military Medical Sciences Introduces
Reagent to Test Drug Resistance of HBV II-31
SIAL Unveils SYBR Green Extract-N-Amp Tissue PCR Kit II-31
Aldrich Introduces LAB Reagents II-32
Kreatech Rolls Out RNA ampULSe Amplification and Labeling Kits II-32
bioMerieux Launches NucliSens miniMAG and NucliSens Magnetic
Extraction Reagents II-32

7. RECENT INDUSTRY ACTIVITY II-33
Danaher Acquires Beckman Coulter II-33
Merck Acquires Millipore II-33
Accuri Cytometers and eBioscience Sign Global Partnership
Agreement II-34
Thermo Fisher Scientific to Acquire Fermentas II-34
Leica Microsystems Completes Genetix Acquisition II-35
Blue Sky Biotech Collaborates with Protein Attachment
Technologies II-35
AnaSpec Announces Distributor Agreement with Yope Biotechnology II-35
Commonwealth Biotechnologies Inks Agreement with Wise Century
Group II-36
Millipore Acquires Guava II-36
Idaho Technology and Kapa Biosystems Ink Licensing Agreement II-36
ChanTest Takes Over ACS II-37
CBI Divests Genetic and Bio-Analytical Testing Business to
Bostwick II-37
Eurogentec to Acquire AnaSpec Inc II-37
Merck Acquires BGIP II-38
Akron Biotech Merges with AppliChem II-38
Fisher HealthCare Inks Distribution Agreement with Dako II-38
PerkinElmer Enters into Agreement with BioLegend II-39
Premier Purchasing Partners and Helena Laboratories Sign
Agreement II-39

8. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-40
Invitrogen and Applied Biosystems Merge to Form Life Technologies II-40
Affymetrix Takes Over Panomics II-40
Thermo Fisher Takes Over Affinity BioReagents II-40
Carna Biosciences Enters into Supply Agreement with Caliper
Life Sciences II-40
Affymetrix Acquires USB Corporation II-41
FASgen and Tetracore Ink Collaboration Agreement II-41
Prodesse and Quidel Ink a Co-Commercialization Agreement II-41
Bexion and MTTI to Collaborate for New Nanovesicle II-42
BD Acquires Cytopeia II-42
Affymetrix Acquires USB II-42
Millipore and Guava Technologies Enter into Collaboration II-42
Hologic Agrees to Acquire Third Wave II-43
Spartan Bioscience and TrimGen Enter into Partnership II-43
Multispan and Promega to Co-Develop Assay Tools II-44
STEMCELL Joins Forces with Geron II-44
HistoRx Signs Agreement with Eli Lilly II-44
GE Healthcare to Take Over Whatman II-45
Inverness Takes Over BBI II-45
Medical Solutions to Take Over Autogen II-45
Sysmex and bioMerieux Agree to Establish a Joint Venture II-45
Miltenyi Acquires Medic II-46
China Medical Acquires Beijing Bio-Ekon II-46
Gene Bridges Partners with Mbiotech II-46
Roche Acquires Ventana Medical II-46
BioMerieux to Shutdown Boxtel Facility II-47
Abbott Inks Agreement with Premier II-47
Beckman Coulter Acquires Dako’s Flow Cytometry Instrumentation
Business II-47
Cliniqa Acquires the Assets of Reagents Applications II-47
Frontier Scientific Acquires Echelon Biosciences II-48
Immucor Signs Supply Agreement with American Red Cross II-48
Ventana Medical Takes Over Spring BioScience II-48
TriLink Biotechnologies Inks Agreement with Applied Biosystems II-49
Bio-Rad Takes Over DiaMed Holdings II-49
PerkinElmer Takes Over ViaCell II-49
Sigma-Aldrich in Alliance with Sangamo BioSciences II-49
Fitzgerald Industries Takes Over Cortex Biochem’s
Immunoreagent Business II-50
Agilent Technologies Acquires Stratagene II-50
Dendritic Signs Supply Agreement with EMD Biosciences II-50
Spectral Diagnostics Inks Agreement with Bio-Rad II-51
Japanese Atol Plans to Acquire a Major Stake in Naha Yakuhin II-51
Roche Takes Over NimbleGen II-51
Roche Takes Over BioVeris II-51
Roche Acquires 454 Life Sciences II-52
Sysmex and Roche Diagnostics Extend Distribution Agreement II-52
Invitrogen and Biocon Inks Exclusive Marketing Agreement II-52
PerkinElmer Acquires Remaining Stake in PerkinElmer India II-52
Promega Enters Into Alliance with Guangzhou Institute II-53
Adaltis Acquires Shanghai Hua Tai Biotechnology II-53
ABR-Affinity Inks Distribution Agreements with Genesis and Good
Biotech II-53
The PLSG Makes Financial Investment in AIT II-54
Numira Merges with Visual Influence II-54
Abbott Receives FDA Clearance for CELL-DYN Rubyâ„¢ II-54
Tm Bioscience Bags Supply Contract JMC II-55
ReaMetrix Receives Clearance for Accuford Tri-T Stat II-55
Panomics Establishes New Subsidiary in Europe II-55
Promega Completes Benitec Acquisition II-55
NCGC Joins Forces with PerkinElmer II-55
MBL Acquires Antibody Business of LifeSpan BioSciences II-56
Sigma-Aldrich and Genospectra Sign a Series of Agreements II-56
Nitragin Completes the Acquisition of Agribiotics II-56
Fujirebio Diagnostics Acquires CanAg Diagnostics II-57
Chemicon Inks an Agreement with ASCC II-57
Takara Bio. Pharma Acquires Stakes in Takara Biotechnology II-57
Millipore Takes Over Serologicals II-57
Serologicals Takes Over LINCO II-57
Genospectra Merges with Panomics II-58
Roche Enters into Three-Year Contract with Premier II-58
KREATECH and GenTel Enter into Distribution Agreement II-58
Kreatech Enters into Supply Agreement with QIAGEN II-58
Invitrogen to Provide Reagents for Genome Sequencing of Solexa II-58
VWR International to Market Biocare Equipment and Reagents in IHC II-59
Biocare Partners with Epitomics for Reagents II-59
GE and CytoGenix Form an Alliance II-59
Fisher Biosciences Joins Forces with Dyomics II-59
PerkinElmer Partners with NCGC II-59
SAFC-Biosciences Formed to Support Sigma-Aldrich II-60
Takara Bio Takes Over Clontech II-60
Techne's Subsidiary Pockets BiosPacific and Fortron Bio Science II-60
QIAGEN Obtains Nextal II-60
Invitrogen Takes Over Caltag II-60
Invitrogen Takes Over Biosource International II-60
Serologicals Acquires Specialty Media from Sentigen II-61
Invitrogen Acquires Zymed Laboratories II-61
Biotage Acquires Argonaut Technologies II-61
Invitrogen Acquires Dynal Biotech II-61
Vita and Cortex Biochem Enter into Distribution Agreement II-61
SIAL and OXB Sign an Agreement for Commercializing LentiVector
Technology II-61
Funakoshi and Affibody Sign a Distribution Agreement II-62
KREATECH and GenTel Enter into Marketing Agreement II-62
KREATECH and Ambion Enter into Supply Agreement II-62
SIAL Enters into Distribution Agreement with MedAssets II-62
IBT Signs Distribution Contracts for Enzymes II-62
Epitome Signs a License Agreement with EMD Biosciences II-63
Consorta Inks Multiple Agreements with Dade Behring II-63
SCS and Chemicon Sign an Agreement for ES Cell Media II-63
LSBC and BioCatalytics Enter into Collaborative Agreement for
Producing Enzymes II-63
Chemicon International Enters into an Agreement with QDC II-63
Dharmacon Signs an Agreement with Genentech II-64
Invitrogen Partners with PerkinElmer II-64
Chemicon and Axordia Collaborate for New Antibody Markers II-64
eGene Enters into Strategic Alliance with Transgenomic II-64
Cancer Genetics Selects Genetics Specialities II-65
Clinical Data Bags Distribution Rights for Hematology
Analyzers and Reagents II-65
BD Biosciences to Expand Production in Puerto Rico II-65
Olympus Enlarges RandD Unit in Ireland II-65
Olympus Begins Production of Immunoassay Reagents II-65
Koon-wah Leong, Shery Guo and Suyue Qian Produces Multilayer
Test Strips II-65
CMT Sells off Specialty Media Division II-65
CSL Divests Cell Culture Reagent Business to Sigma-Aldrich II-66
BD Divests Clontech Business II-66

9. FOCUS ON SELECT PLAYERS WORLDWIDE II-67
Abbott Diagnostics (USA) II-67
Beckman Coulter, Inc. (USA) II-67
Becton Dickinson and Company (USA) II-68
BioMerieux SA (France) II-68
EMD Biosciences, Inc. (USA) II-68
EMD Millipore Corporation (USA) II-68
Fitzgerald Industries International (USA) II-69
GE Healthcare (UK) II-69
Life Technologies Corp. (USA) II-70
Ortho-Clinical Diagnostics (USA) II-70
PerkinElmer, Inc. (USA) II-70
Promega Corp. (USA) II-71
Roche Diagnostics Ltd. (Switzerland) II-71
Siemens Healthcare Diagnostics, Inc. (USA) II-71
Sigma - Aldrich (USA) II-72

10. GLOBAL MARKET PERSPECTIVE II-73
Table 1: World Recent Past, Current and Future Market Analysis
for Biotechnology Reagents by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Latin
America Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-73

Table 2: World Historic Review for Biotechnology Reagents by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-74

Table 3: World 15-Year Perspective for Biotechnology Reagents
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan)
and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-75
World Market for Biotechnology Reagents by Product Segment II-76
Table 4: World Recent Past, Current and Future Market Analysis
for Cell / Tissue Culture Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-76

Table 5: World Historic Review for Cell / Tissue Culture
Reagents by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin America Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-77

Table 6: World 15-Year Perspective for Cell / Tissue Culture
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding
Japan) and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-78

Table 7: World Recent Past, Current and Future Market Analysis
for DNA Sequencing / Synthesis Reagents by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-79

Table 8: World Historic Review for DNA Sequencing / Synthesis
Reagents by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin America Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-80

Table 9: World 15-Year Perspective for DNA Sequencing /
Synthesis Reagents by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) II-81

Table 10: World Recent Past, Current and Future Market Analysis
for Electrophoresis Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-82

Table 11: World Historic Review for Electrophoresis Reagents
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-83

Table 12: World 15-Year Perspective for Electrophoresis
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-84

Table 13: World Recent Past, Current and Future Market Analysis
for Flow Cytometry Reagents by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Latin
America Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-85

Table 14: World Historic Review for Flow Cytometry Reagents by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-86

Table 15: World 15-Year Perspective for Flow Cytometry
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-87

Table 16: World Recent Past, Current and Future Market Analysis
for Immunoassay Reagents by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Latin
America Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-88

Table 17: World Historic Review for Immunoassay Reagents by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-89

Table 18: World 15-Year Perspective for Immunoassay Reagents
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan)
and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-90

Table 19: World Recent Past, Current and Future Market Analysis
for Liquid Chromatography Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-91

Table 20: World Historic Review for Liquid Chromatography
Reagents by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin America Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-92

Table 21: World 15-Year Perspective for Liquid Chromatography
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-93

Table 22: World Recent Past, Current and Future Market Analysis
for Polymerase Chain Reaction Reagents by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-94

Table 23: World Historic Review for Polymerase Chain Reaction
Reagents by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin America Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-95

Table 24: World 15-Year Perspective for Polymerase Chain
Reaction Reagents by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Markets for Years 2003,
2011 and 2017 (includes corresponding Graph/Chart) II-96

Table 25: World Recent Past, Current and Future Market Analysis
for Protein Synthesis Reagents by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin America Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-97

Table 26: World Historic Review for Protein Synthesis Reagents
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Latin America Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-98

Table 27: World 15-Year Perspective for Protein Synthesis
Reagents by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Latin America Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-99


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Biotech Industry in the US III-1
Escalating Demand for Biomedical Research Reagents and Kits III-1
Application-Oriented Products Herald a Technological Upheaval III-1
Competition - Highly Prevalent III-1
Review of US Cell/Tissue Culture Supplies Market III-2
Industrial Segment - Largest End-User III-2
Rise in Cell Culture Equipment Demand Leads to Innovation III-3
Factors Influencing the Market for Media III-3
Fetal Bovine Serum - Use on a Decline III-3
Table 28: Leading Producers of Fetal Bovine Serum in the
US (2011): Percentage Breakdown of Value Sales for Life
Technologies, Thermo Scientific (Hyclone), and Others
(includes corresponding Graph/Chart) III-3
Suppliers Searching for New Areas III-3
Serum Free Products Market: Rapidly Growing III-4
Immunoassay Reagents III-4
Table 29: Leading Players in the US Immunoassay Reagents
Market (2011): Percentage Breakdown of Value Sales for
Abbott Diagnostics, Siemens, Roche Diagnostics, Beckman
Coulter, and Others (includes corresponding Graph/Chart) III-4
Issues Affecting the US Immunodiagnostics Market III-4
Technological Innovations Play a Vital Role III-5
Chromatography Reagents Market to Register Steady Growth III-5
Table 30: US Market for Chromatography Reagents (2011):
Percentage Breakdown of Sales of Reagents by Application/
Technique) (includes corresponding Graph/Chart) III-5
Molecular Biological Reagents III-6
Rapidly Growing Market III-6
Table 31: Molecular Biology Reagents Market in the US
(2011): Percentage Breakdown of Value Sales by End use for
Academic User, Biotech industry, Pharmaceuticals, and
Government (includes corresponding Graph/Chart) III-6
DNA Sequencing: Gaining Prominence III-6
B.Market Analytics III-7
Table 32: The US Recent Past, Current and Future Analysis for
Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-7

Table 33: The US Historic Review for Biotechnology Reagents
by Product Segment - Cell/Tissue Culture Reagents, DNA
Sequencing/ Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-8

Table 34: The US 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for 2003, 2011 and 2017 (includes
corresponding Graph/Chart) III-9

2. CANADA III-10
A.Market Analysis III-10
Biotech Sector in Canada III-10
Outlook III-10
B.Market Analytics III-11
Table 35: Canadian Recent Past, Current and Future Analysis
for Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-11

Table 36: Canadian Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-12

Table 37: Canadian 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for 2003, 2011 and 2017 (includes
corresponding Graph/Chart) III-13

3. JAPAN III-14
A.Market Analysis III-14
Biotech Scenario III-14
Outlook III-15
Table 38: Japanese Market for Biotechnology (2011):
Percentage Breakdown of Revenues by End-Use Application -
Medical Care, Food, Bio Tools and Information, Environment and
Energy, and Others (includes corresponding Graph/Chart) III-15
B.Market Analytics III-16
Table 39: Japanese Recent Past, Current and Future Analysis
for Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-16

Table 40: Japanese Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-17

Table 41: Japanese 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for 2003, 2011 and 2017 (includes
corresponding Graph/Chart) III-18

4. EUROPE III-19
A.Market Analysis III-19
Biotechnology in Europe on an Expansion Spree III-19
PCR Technology - An Overview III-19
Technological Advancements Drive PCR Market III-19
B.Market Analytics III-20
Table 42: European Recent Past, Current and Future Analysis
for Biotechnology Reagents by Geographic Region - France,
Germany, Italy, UK, and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) III-20

Table 43: European Historic Review for Biotechnology
Reagents by Geographic Region - France, Germany, Italy, UK,
and Rest of Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) III-21

Table 44: European 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for France, Germany, Italy, UK, and Rest of Europe for
Years 2003, 2011 and 2017 (includes corresponding Graph/Chart) III-22

Table 45: European Recent Past, Current and Future Analysis
for Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-23

Table 46: European Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-24

Table 47: European 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/ Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-25

4a. FRANCE III-26
Market Analytics III-26
Table 48: French Recent Past, Current and Future Analysis for
Biotechnology Reagents by Product Segment - Cell/ Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-26

Table 49: French Historic Review for Biotechnology Reagents
by Product Segment - Cell/Tissue Culture Reagents, DNA
Sequencing/ Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-27

Table 50: French 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-28

4b. GERMANY III-29
A.Market Analysis III-29
German Biotech Industry in Retrospective III-29
Outlook III-29
B.Market Analytics III-30
Table 51: German Recent Past, Current and Future Analysis for
Biotechnology Reagents by Product Segment - Cell/ Tissue
Culture Reagents, DNA Sequencing/Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-30

Table 52: German Historic Review for Biotechnology Reagents
by Product Segment - Cell/Tissue Culture Reagents, DNA
Sequencing/ Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-31

Table 53: German 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/ Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-32

4c. ITALY III-33
Market Analytics III-33
Table 54: Italian Recent Past, Current and Future Analysis for
Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/ Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-33

Table 55: Italian Historic Review for Biotechnology Reagents
by Product Segment - Cell/Tissue Culture Reagents, DNA
Sequencing/ Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-34

Table 56: Italian 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-35

4d. THE UNITED KINGDOM III-36
A.Market Analysis III-36
Research Entities III-36
Commercial Activities III-36
B.Market Analytics III-37
Table 57: The UK Recent Past, Current and Future Analysis for
Biotechnology Reagents by Product Segment - Cell/Tissue
Culture Reagents, DNA Sequencing/ Synthesis Reagents,
Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-37

Table 58: The UK Historic Review for Biotechnology Reagents
by Product Segment - Cell/Tissue Culture Reagents, DNA
Sequencing/ Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-38

Table 59: The UK 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-39

4e. REST OF EUROPE III-40
A.Market Analysis III-40
Medical Device Market in Spain III-40
Russian Clinical Diagnostic Equipment and Supplies Market III-40
B.Market Analytics III-41
Table 60: Rest of Europe Market for Biotechnology Reagents -
Recent Past, Current and Future Analysis by Product Segment
for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis
Reagents, Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-41

Table 61: Rest of Europe Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-42

Table 62: Rest of Europe 15-Year Perspective for
Biotechnology Reagents by Product Segment - Percentage
Breakdown of Dollar Sales for Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-43

5. ASIA-PACIFIC III-44
A.Market Analysis III-44
Biotechnology - A Burgeoning Market III-44
Impact of IPR on Biotechnology Market III-44
Asia-Pacific - A Lucrative RandD Base III-44
Focus on Key Biotechnology Markets III-45
India III-45
China III-45
Korea III-46
Clinical Lab Products Market in Korea III-46
B.Market Analytics III-47
Table 63: Asia-Pacific Market for Biotechnology Reagents -
Recent Past, Current and Future Analysis by Product Segment
for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis
Reagents, Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-47

Table 64: Asia-Pacific Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-48

Table 65: Asia-Pacific 15-Year Perspective for Biotechnology
Reagents by Product Segment - Percentage Breakdown of Dollar
Sales for Cell/Tissue Culture Reagents, DNA Sequencing/
Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry
Reagents, Immunoassay Reagents, Liquid Chromatography
Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-49

6. LATIN AMERICA III-50
A.Market Analysis III-50
The Brazilian Biotech Industry: An Overview III-50
Table 66: Biotechnology Industry in Brazil (2011):
Percentage Breakdown of Revenues Generated by State
(includes corresponding Graph/Chart) III-50

Table 67: Biotechnology Industry in Brazil (2011):
Percentage Breakdown by End-Use Sector - Human Health,
Government and International Biotechnology Companies,
Consumables Suppliers, Equipment, Agribusiness, Animal
Health, and Environment (includes corresponding
Graph/Chart) III-51
B.Market Analytics III-52
Table 68: Latin American Market for Biotechnology Reagents -
Recent Past, Current and Future Analysis by Product Segment
for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis
Reagents, Electrophoresis Reagents, Flow Cytometry Reagents,
Immunoassay Reagents, Liquid Chromatography Reagents,
Polymerase Chain Reaction Reagents, and Protein Synthesis
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-52

Table 69: Latin American Historic Review for Biotechnology
Reagents by Product Segment - Cell/Tissue Culture Reagents,
DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents,
Flow Cytometry Reagents, Immunoassay Reagents, Liquid
Chromatography Reagents, Polymerase Chain Reaction Reagents,
and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-53

Table 70: Latin American 15-Year Perspective for
Biotechnology Reagents by Product Segment - Percentage
Breakdown of Dollar Sales for Cell/Tissue Culture Reagents,
DNA Sequencing/ Synthesis Reagents, Electrophoresis
Reagents, Flow Cytometry Reagents, Immunoassay Reagents,
Liquid Chromatography Reagents, Polymerase Chain Reaction
Reagents, and Protein Synthesis Reagents Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) III-54


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 267 (including Divisions/Subsidiaries - 324)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 195
Canada 10
Japan 6
Europe 93
France 6
Germany 22
The United Kingdom 26
Italy 11
Spain 2
Rest of Europe 26
Asia-Pacific (Excluding Japan) 18
Latin America 2
------------------------------------------

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Analysis of the Global In Vitro Diagnostics Market

Analysis of the Global In Vitro Diagnostics Market

  • $ 10 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

  • $ 7 302
  • Industry report
  • August 2014
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for chemical and physical analysis equipment in different Asian countries. ...

Global Immunoassay Systems Market

September 2014 $ 4 950

Global Cholesterol Testing Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.